Otsuka Europe News and Activities

Otsuka Europe is owned by Otsuka Holdings.

Otsuka Holdings is one of the...

• Forbes Global 2000 (#654);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Otsuka Holdings is a company listed under the stock ticker 4578 (JP).

Otsuka Holdings has a direct presence in 11 countries.

Otsuka Holdings has 23 subsidiaries including Araris Biotech, Cambridge Isotope Laboratories and Interpharma.

They are in:

• Pharmaceuticals46%
• Medical Equipment29%
• Other25%

View the org chart displaying its 20 main executives

Most searched biographies at Otsuka Europe

• Andrew Hodge, Chief Executive Officer
• Paul Geary, Vice President of Ethics and Compliance
• Nick Craig, Vice President, Finance and Business Services

Create your alert
to follow the executive moves at Otsuka Europe.

Otsuka Holdings has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Otsuka Europe

Social media about Otsuka Europe

• Otsuka Europe on Wikipedia, Google News & Yahoo Finance
• Otsuka Europe on LinkedIn, X (Twitter) & YouTube